The Egyptan International Company for Pharma Industries (EIPICO) will start production on its third plant in May, thelocal press reports. The factory, based in the Tenth of Ramadan City, cost EIPICO EGP 1 bn and is expected to contribute to the government’s fight against the covid-19 outbreak by producing genetically modified proteins.
More from Enterprise
Egypt continues to issue LCs as usual
LCs continue to be processed — albeit after closer inspection…
EGX kicks off first day of futures trading on the EGX
The rollout includes 3- and 6-month future contracts tracking the…
Beltone to launch Fadda, Egypt’s first-ever silver investment fund
Good afternoon, friends, and (almost) Eid Mubarak. With Ramadan on…
How Egypt’s fintech players can own the digital Eidiya evolution
💸 Eid traditions in Egypt (and the region) have held…